Search

Your search keyword '"Azevedo V. F."' showing total 36 results

Search Constraints

Start Over You searched for: Author "Azevedo V. F." Remove constraint Author: "Azevedo V. F."
36 results on '"Azevedo V. F."'

Search Results

1. AB1316 SAFETY AND IMMUNOGENICITY OF TWO HETEROLOGOUS VACCINE SCHEDULES AGAINST SARS-CoV-2 IN PATIENTS WITH RHEUMATOID ARTHRITIS: BRAZILIAN MULTICENTER STUDY

2. POS0274 PROSPECTIVE EVALUATION OF THE EFFECT OF THE VACCINE AGAINST SARS-COV-2 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM SAFER STUDY

5. POS0271 HETEROLOGOUS COVID-19 BOOSTER VACCINATION PRODUCED GREATER ANTIBODY TITERS IN AUTOIMMUNE DISEASE PATIENTS: DATA FROM MULTICENTRIC PROSPECTIVE PHASE IV SAFER STUDY

7. POS1285 IMMUNOGENICITY AND SAFETY OF THE CHADOX 1 COVID-19 VACCINE IN PATIENTS WITH AUTOIMMUNE DISEASES AND HEALTHY CONTROLS: DATA FROM SAFER STUDY

8. AB0522 SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS IN PATIENTS WITH PSORIATIC ARTHRITIS: AN INTEGRATED ANALYSIS FROM THE PHASE 3 PROGRAM

12. FRI0332 EVALUATION OF THE INDIVIDUAL COMPONENTS OF ACR50+PASI100 AND MDA AT WEEK 24 FROM THE SPIRIT-H2H TRIAL COMPARING THE EFFICACY AND SAFETY OF IXE VERSUS ADA IN PATIENTS WITH PSA NAÏVE TO BDMARDS

13. SAT0345 IS THERE A DIFFERENCE BETWEEN THE SEXES IN THE RATE OF PROGRESSION OF SYSTEMIC SCLEROSIS-ASSOCIATED ILD (SSC-ILD)? DATA FROM THE SENSCIS TRIAL

16. Update of EULAR recommendations for the treatment of systemic sclerosis

17. What have multicentre registries across the world taught us about the disease features of systemic sclerosis?

18. Correction to: PANLAR consensus statement on biosimilars

19. PANLAR consensus statement on biosimilars

22. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database

23. CARACTERIZAÇÃO DE NANOFLUIDOS PARA UTILIZAÇÃO EM COMPRESSORES DE REFRIGERAÇÃO: DETERMINAÇÃO DA VISCOSIDADE DINÂMICA, CONDUTIVIDADE TÉRMICA E ESTABILIDADE.

25. METOTREXATO NO TRATAMENTO DA SÍNDROME SAPHO COMPLICADA POR QUELÓIDES.

26. Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: Analysis of the Brazilian registry of spondyloarthritis

27. Effect of age at disease onset in the clinical profile of spondyloarthritis: A study of 1424 Brazilian patients

28. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort

29. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis

30. The gut microbiota profile in psoriasis: a Brazilian case-control study.

31. Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients.

32. Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab.

33. [Methotrexate to treat SAPHO syndrome with keloidal scars].

34. [Acute toxoplasmosis infection in a patient with ankylosing spondylitis treated with adalimumab: a case report].

35. [Could Aleijadinho have suffered from scleroderma].

36. Microalbuminuria and renal morphology in the evaluation of subclinical lupus nephritis.

Catalog

Books, media, physical & digital resources